Biography

Prof. Andrea De Gottardi

Ente Ospedaliero Cantonale (EOC), Switzerland

Professor


Email: [email protected]; [email protected]


Qualifications

2002 Ph.D., University of Berne, Switzerland

1999 M.Sc., University of Berne, Switzerland

1994 B.Sc., University of Lausanne, Switzerland


Publications (Selected)

  1. Garcia-Pagan, J.C., Gluud, L.L., Mandorfer, M., Schattenberg, J.M. and others. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo‐controlled exploratory study. British Journal of Clinical Pharmacology, 92(5):1326-1338, 2026.

  2. Ramier, C., Hernandez-Gea, V., Elkrief, L., Berzigotti, A., De Gottardi, A. and others. Fatigue, depression, and impaired health-related quality of life in patients with vascular liver diseases: a multicentric European study. JHEP Reports, 101861, 2026.
  3. de Gottardi, A. and Klapdor, S. Sub-Acute Budd-Chiari Syndrome. SPMI Case Reports, 4(Special Issue):16-19, 2026.
  4. Engelmann, C., Verma, N., Qi, T., Kerbert, A.J.C., Pohl, J., Morgan, C., Kowalski, M. and others. Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts. Journal of Hepatology, 5, 2026.
  5. Bersuch, L.A. and De Gottardi, A. Exploring Maralixibat for Treatment-Resistant Pruritus in Intrahepatic Cholestasis of Pregnancy and Primary Biliary Cholangitis: A Case Report. The American Journal of Case Reports, 26, e949019, 2025.
  6. Bersuch, L.A. and De Gottardi, A. Use of Maralixibat for treatment-resistant pruritus in intrahepatic cholestasis of pregnancy: A case report. Swiss Medical Weekly, 155, 2025.
  7. Daminet, J., Sinnreich, M.F., Kremer, A.E., De Gottardi, A., Stirnimann, G. and others. Ursodeoxycholic acid response in the Swiss Primary Biliary Cholangitis Cohort Study. Swiss Medical Weekly, 155, 2025.
  8. Bettinger, D., Berzigotti, A., Mandorfer, M., Ripoll, C., Labenz, C., Zizer, E. and others. Transjugular diagnostic procedures in hepatology: indications, techniques and interpretation. JHEP Reports, 7(8), 101437, 2025.
  9. Rüfer, A., Brand, C., de Gottardi, A., Fischli, S., Melzer, R., Odermatt, U. and others. Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report, review of the literature and expert opinion. Therapeutic Advances in Hematology, 16, 20406207251338942, 2025.
  10. Patidar, K.R., Ma, A.T., Juanola, A., Barone, A., Incicco, S., Kulkarni, A.V. and others. Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. The Lancet Gastroenterology & Hepatology, 10(5):418-430, 2025.
  11. Juanola, O., Coutry, N., Felber, M., Yilmaz, B., Sorrenti, E., Iezzi, G., Birrer, F. and others. TOP-443 Paneth cells regulate intestinal lymphangiogenesis and lipid metabolism in metabolic dysfunction-associated steatotic liver disease. Journal of Hepatology, 82, S582, 2025.
  12. Scherer, R. and De Gottardi, A. Kombinationstherapie von Carvedilol und Varizenligatur zur Primärprävention einer Varizenblutung bei Patienten mit Leberzirrhose und High-risk-Varizen. Schweizer Gastroenterologie, 6(1):35-38, 2025.
  13. Ramier, C., Hernández-Gea, V., Elkrief, L., Berzigotti, A., Antonenko, A. and others. SAT-333 Quality of life of patients living with vascular LIVEr diseaseS: Results of the LIVES european project. Journal of Hepatology, 82, S727, 2025.
  14. Magaz, M., Giudicelli-Lett, H., Abraldes, J.G., Nicoară-Farcău, O., Turon, F. and others. Porto-sinusoidal vascular liver disorder with portal hypertension: natural history and long-term outcome. Journal of Hepatology, 82(1):72-83, 2025.
  15. Felber, M., Wyss, L., Wolfisberg, T., Juanola, O., Moghadamrad, S. and others. Beta-Adrenergic Drive Impairs Gut-vascular Barrier (GVB): Mechanism Involved in small intestinal-barrier Dysfunction in Cirrhosis and Acute-on-chronic Liver Failure (ACLF). Swiss Medical Weekly, 154, 7S, 2024.
  16. Elkrief, L., Hernandez-Gea, V., Senzolo, M., Albillos, A., Baiges, A., Berzigotti, A. and others. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies. The Lancet Gastroenterology & Hepatology, 9(9):859-883, 2024.
  17. Larrue, H., Allaire, M., Weil‐Verhoeven, D., Barge, S., Thabut, D., Payance, A. and others. French guidelines on TIPS: Indications and modalities. Liver International, 44(9):2125-2143, 2024.
  18. Portela, C.P., Gautier, L.A., Zermatten, M.G., Fraga, M., Moradpour, D. and others. Direct oral anticoagulants in cirrhosis: Rationale and current evidence. JHEP Reports, 6(8), 101116, 2024.
  19. Dietz, J., Graf, C., Berg, C.P., Port, K., Deterding, K., Buggisch, P., Peiffer, K.H. and others. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients. JHEP Reports, 6(7), 101072, 2024.
  20. Garcia-Pagan, J.C., Gluud, L.L., Mandorfer, M., Schattenberg, J.M. and others. Effects of Zibotentan and Dapagliflozin on patients with compensated cirrhosis: A randomized placebo controlled exploratory pilot study. Proceedings of the European Association for the Study of the Liver, Milan, 2024.


Personal Details

https://www.epatocentro.ch/en/The-centre/The-people/Consultants/Andrea-De-Gottardi

https://scholar.google.com/citations?user=FCVUxq8AAAAJ&hl=en

https://www.researchgate.net/profile/Andrea-De-Gottardi

WoS Researcher ID: AAN-7512-2020

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top